Pietro Vittozzi
Overview
Explore the profile of Pietro Vittozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gualano G, Musso M, Mencarini P, Mosti S, Cerva C, Vittozzi P, et al.
Antibiotics (Basel)
. 2025 Jan;
14(1.
PMID: 39858293
: Tuberculosis (TB) is preventable and curable, but multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) pose significant challenges worldwide due to the limited treatment options, lengths of therapies, and...
2.
Licata M, Mencarini P, Mastrobattista A, Carli S, Cerva C, Mosti S, et al.
Pathogens
. 2025 Jan;
13(12.
PMID: 39770324
Diagnosing non-tuberculous mycobacterial pulmonary disease (NTM-PD) in patients unable to produce sputum spontaneously requires invasive procedures to obtain valid respiratory specimens. In this retrospective study, we evaluated the results of...
3.
Mondi A, Mastrorosa I, Piselli P, Cimaglia C, Matusali G, Carletti F, et al.
J Med Virol
. 2023 May;
95(6):e28831.
PMID: 37246793
Despite the higher transmissibility of Omicron Variant of Concern (VOC), several reports have suggested lower risk for hospitalization and severe outcomes compared to previous variants of SARS-CoV-2. This study, enrolling...
4.
Di Gennaro F, Gualano G, Timelli L, Vittozzi P, Di Bari V, Libertone R, et al.
Antibiotics (Basel)
. 2021 Apr;
10(3).
PMID: 33800406
Background: The WHO advised that the impact of COVID-19 pandemic on TB services was estimated to be dramatic due to the disruption of TB services. Methods: A retrospective data collection...
5.
Petrone L, Petruccioli E, Vanini V, Cuzzi G, Gualano G, Vittozzi P, et al.
Int J Infect Dis
. 2021 Mar;
113 Suppl 1:S82-S87.
PMID: 33713816
Objectives: The interaction of COVID-19 and tuberculosis (TB) are still poor characterized. Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and SARS-CoV-2 using a whole-blood-based assay-platform in...
6.
Lorenzini P, Di Gennaro F, Girardi E, Abbonizio M, Abdeddaim A, Agostini E, et al.
Int J Infect Dis
. 2021 Mar;
105:532-539.
PMID: 33676001
Background: Limited data are available about the predictors and outcomes associated with prolonged SARS-CoV-2 RNA shedding (VS). Methods: A retrospective study including COVID-19 patients admitted to an Italian hospital between...
7.
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
Petrone L, Petruccioli E, Alonzi T, Vanini V, Cuzzi G, Fard S, et al.
J Infect
. 2021 Feb;
82(4):58-66.
PMID: 33639176
Objective: Baricitinib seems a promising therapy for COVID-19. To fully-investigate its effects, we in-vitro evaluated the impact of baricitinib on the SARS-CoV-2-specific-response using the whole-blood platform. Methods: We evaluated baricitinib...
8.
Petrone L, Petruccioli E, Vanini V, Cuzzi G, Fard S, Alonzi T, et al.
Clin Microbiol Infect
. 2020 Oct;
27(2):286.e7-286.e13.
PMID: 33045370
Objectives: To examine whether specific T-cell-responses to SARS-CoV-2 peptides can be detected in COVID-19 using a whole-blood experimental setting, which may be further explored as a potential diagnostic tool. Methods:...
9.
Di Gennaro F, Vittozzi P, Gualano G, Musso M, Mosti S, Mencarini P, et al.
Antibiotics (Basel)
. 2020 Aug;
9(8).
PMID: 32784552
Tuberculosis (TB) in the elderly (>65 years old) has increasingly become a global health problem. It has long been recognized that older people are vulnerable to developing tuberculosis. We retrospectively...
10.
Gualano G, Musso M, Mosti S, Mencarini P, Mastrobattista A, Pareo C, et al.
Int J Infect Dis
. 2020 May;
97:174-176.
PMID: 32437932
Objective: To report a clinical case of a patient with a compatible HRCT scan and two negative SARS-CoV-2 RNA upper respiratory tract specimens but with a confirmed viral infection by...